| Serum biomarkers for the evaluation of liver fibrosis: The need for better tests | Müjdat ZEYBEL,Ramazan İDİLMAN | 377–378 |
| Does Helicobacter pylori infection influence the major postoperative complication rate after sleeve gastrectomy? A retrospective cohort study in an endemic region | KÜRŞAT RAHMİ SERİN,Ümit AKYÜZ,BURÇİN BATMAN,Derya SALİM UYMAZ,HASAN ALTUN | 379–383 |
| Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? | Raim İLİAZ,Filiz AKYÜZ,Gülçin YEĞEN,Aslı ÖRMECİ,Suut GÖKTÜRK,Ümit AKYÜZ,Bülent BARAN,Özlem MUTLUAY,Sami EVİRGEN,Çetin KARACA,Kadir DEMİR,Fatih BEŞIŞIK,MİNE GÜLLÜOĞLU,Sabahattin KAYMAKOĞLU | 384–391 |
| Detection and clinical significance of DNA repair gene ERCC8 tag SNPs in gastric cancer | Xingre LU,Fengyu CHEN,Xiaowen LIU,Yunju Zİ,Diao YUAN,Xiang HE,Deyong ZHU | 392–396 |
| Diagnostic accuracy of fecal calprotectin for screening patients with colorectal cancer: A meta-analysis | Xiaohua YE,Jiaping HUAİ | 397–405 |
| Predictive parameters of early postoperative complications in Crohn’s disease: Single team experienc | Deniz ATASOY,Afag AGHAYEVA,İSMAİL AHMET BİLGİN,Yusuf ERZİN,İlknur Erenler BAYRAKTAR,BİLGİ BACA,TAYFUN KARAHASANOĞLU,İSMAİL HAKKI HAMZAOĞLU | 406–410 |
| Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey | Ece ESİN,FERAH YILDIZ,Şahin LAÇİN,Yusuf KARAKAŞ,MELİS GÜLTEKİN,ÖMER DİZDAR,ŞUAYİB YALÇIN | 411–418 |
| Physicians’ attitude and perception regarding celiac disease: A questionnaire-based study | Mariana JINGA,Alina POPP,Daniel Vasile BALABAN,Alina DİMA,Ciprian JURCUT | 419–426 |
| Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk | Fahri BİLGİÇ,Emre GERÇEKER,SEDA ÖRENAY BOYACIOĞLU,ELMAS KASAP,Ufuk DEMİRCİ,Hatice YILDIRIM,Ahmed Ramiz BAYKAN,Hakan YÜCEYAR | 427–435 |
| Lesion size determines diagnostic yield of EUS-FNA with onsite cytopathologic evaluation for upper gastrointestinal subepithelial lesions | Tan ATTİLA,Özlem AYDIN ALTUNTAŞ | 436–441 |